Observational studyBMC pulmonary medicine2026
Building and externally validating a prediction model for long COVID in severe and critical COVID-19 patients: a multi-center cohort study.
Observational study in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the risk factors of Long COVID and to construct a nomogram to predict the occurrence of Long COVID.
methodThis study was an observational study. Clinical data were collected from patients diagnosed with COVID-19 and hospitalized at the First Affiliated Hospital of Jinzhou Medical University Hospital from December 7, 2022, to February 1, 2023. The prediction model was constructed using a nomogram. The clinical data of patients in Panjin Central Hospital Hospital from December 7, 2022 to December 7, 2023 were used for external validation.
resultsIn the development cohort and the validation cohort of this study, 60.3% and 62.3% of the patients developed Long COVID, respectively. After Least absolute shrinkage and selection operator regression, the final variables included in the prediction model were percentage of lymphocyte, the Charlson Comorbidity Index, Computed Tomography score, and oxygen requirement. The Area Under the Receiver Operating Characteristic for external validation of the model is 0.786, and the p value of Spiegelhalter test was 0.126. The p value of the Hosmer and Lemeshow chi-square statistic was 0.098. The decision curve analysis indicates that the model performs well.
conclusionThe prediction model developed in this study is useful for assessing the likelihood of developing Long COVID in hospitalized patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.